Oral Oncology
Volume 38, Issue 8 , Pages 763-771 , December 2002

The presence of candidate tumor suppressor gene loci at chromosome 3p for oral squamous cell carcinomas

Received 13 May 2002 ,Accepted 15 July 2002.

References 

  1. Fearon ER. Tumor suppressor genes. In:  Vogelstein B,  Kinzker KW editor. The genetic basis of human cancer. New York: McGraw-Hill; 1998;p. 229–236
  2. Ishwad CS, Ferrell RE, Appel BN, Johnson JT, Myers EN, Law JC, et al.  Microsatellite instability in oral cancer. Int J Cancer (Pred Oncol). 1995;64:332–335
  3. Ogawara K, Uzawa K, Nakanishi H, Yokoe H, Wang X-L, Tanzawa H, et al.  Frequent microsatellite instability in oral cancer. Oncol Rep. 1997;4:161–165
  4. Weinberg RA. Tumor suppressor genes. Science. 1991;254:1138–1146
  5. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 1990;60:509–520
  6. Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, et al.  Mutations in the p53 gene and human papillomavirus infection as significant prognosis factors in squamous cell carcinomas of the oral cavity. Oncogene. 1996;18:1663–1668
  7. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323:643–646
  8. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, et al.  DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996;271:350–353
  9. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, et al.  Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet. 1994;8:23–26
  10. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943–1947
  11. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, et al.  The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 1996;84:587–597
  12. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, et al.  Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997;15:356–362
  13. Yakushiji T, Noma H, Shibahara T, Arai K, Yamamoto N, Tanaka C, et al.  Analysis of a role for p16/CDKN2 expression and methylation patterns in human oral squamous cell carcinoma. Bull Tokyo Dent Coll. 2001;42:159–168
  14. Imai FL, Uzawa K, Miyakawa A, Shiiba M, Tanzawa H. A detailed deletion map of chromosome 20 in human oral squamous cell carcinoma. Int J Molecular Medicine. 2000;7:43–47
  15. Miyakawa A, Wang X-L, Nakanishi H, Imai FL, Shiiba M, Miya T, et al.  Allelic loss on chromosome 22 in oral cancer: possibility of the existence of a tumor suppressor gene on 22q13. Int J Oncol. 1998;13:705–719
  16. Nakanishi H, Wang X-L, Imai FL, Kato J, Shiiba M, Miya T, et al.  Localization of a novel tumor suppressor gene loci on chromosome 9p21–22 in oral cancer. Anticancer Res. 1999;19:29–34
  17. Ogawara K, Miyakawa A, Shiiba M, Uzawa K, Watanabe T, Wang X-L, et al.  Allelic loss of chromosome 13q14.3 in human oral cancer: Correlation with lymph node metastasis. Int J Cancer. 1998;79:312–317
  18. Ono K, Miyakawa A, Fukuda M, Shiiba M, Uzawa K, Watanabe T, et al.  Allelic loss on the short arm of chromosome 8 in oral squamous cell carcinoma. Oncol Rep. 1999;6:785–789
  19. Partridge M, Emilion G, Langdon JD. LOH at 3p correlates with a poor survival in oral squamous cell carcinoma. Br J Cancer. 1996;73:366–371
  20. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J. Location of candidate tumor suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J Cancer. 1999;83:318–325
  21. Roz L, Wu CL, Porter S, Scully C, Speight P, Read A, et al.  Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res. 1996;56:1228–1231
  22. Uzawa K, Suzuki H, Yokoe H, Tanzawa H, Sato K. Mutational state of p16/CDKN2 and VHL genes in squamous-cell carcinoma of the oral cavity. Int J Oncology. 1995;7:895–899
  23. Uzawa K, Suzuki H, Komiya A, Nakanishi H, Ogawara K, Tanzawa H, et al.  Evidence for two distinct tumor-suppressor gene loci on the long arm of chromosome 11 in human oral cancer. Int J Cancer. 1996;67:510–514
  24. Wang X-L, Uzawa K, Imai Y, Tanzawa H. Localization of a novel tumor suppressor gene associated with human oral cancer on chromosome 4q25. Oncogene. 1999;18:823–825
  25. Watanabe T, Wang X-L, Miyakawa A, Shiiba M, Imai Y, Sato T, et al.  Mutational state of tumor suppressor genes (DCC, DPC4) and alteration on chromosome 18q21 in human oral cancer. Int J Oncol. 1997;11:1287–1290
  26. Yamamoto N, Uzawa K, Miya T, Watanabe T, Yokoe H, Shibahara T, et al.  Frequent allelic loss/imbalance on the long arm of chromosome 21 in oral cancer: Evidence for three distinct tumor suppressor gene loci. Oncol Rep. 1999;6:1223–1227
  27. Arai K, Shibahara T, Yamamoto N, Yakushiji T, Tanaka C, Noma H. Frequent allelic loss/imbalance on the short arm of chromosome 3 in tongue cancer. Bull Tokyo Dent Coll. 2001;42:151–157
  28. Jones MH, Nakamura Y. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene. 1992;7:1631–1634
  29. World Health Organization. International Histological Classification of Tumours; Histological Typing of Oral and Oropharyngeal Tumours. No. 4. Geneva: WHO; 1971;
  30. UICC. TNM Classification of Malignant Tumours. 4th edition. Berlin: Springer; 1987;
  31. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning; A laboratory manual edition 1. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1982;
  32. Komiya A, Suzuki H, Aida S, Yatani R, Shimazaki J. Mutational analysis of CDKN2 (CDK4I/MTS1) gene in tissues and cell lines of human prostate cancer. Jpn J Cancer Res. 1995;86:622–625
  33. Yamamoto E, Miyakawa A, Kohama G. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg. 1984;6:938–947
  34. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260:1317–1320
  35. Ah-See KW, Cooke TG, Pickford IR, Soutar D, Balmain A. An allelotype of squamous cell carcinoma of the head and neck using microsatellite markers. Cancer Res. 1994;54:1617–1621
  36. Field JK, Kiaris H, Risk JM, Tsiriyotis C, Adamson R, Zoumpourlis V, et al.  Allelotype of squamous cell carcinoma of the head and neck: Fractional allele loss correlates with survival. Br J Cancer. 1995;72:1180–1188
  37. Scully C, Field JK. Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma (Review). Int J Oncol. 1997;10:5–21
  38. Partridge M. The biology of cancer. In:  Ward Booth P,  Hausamen J-E,  Schendel S editor. Maxillofacial surgery (1st ed.). London: Churchill Livingstone; 1999;p. 309–324
  39. Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JTC, Kim Y-T, et al.  Loss of FHIT expression in cervical carcinoma cell lines and primary tumor. Cancer Res. 1997;57:4692–4698
  40. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, et al.  FHIT gene alterations in head and neck squamous cell carcinomas. Proc Nat Acad Sci (Wash). 1996;93:9770–9775
  41. Muller CY, O'Boyle JD, Fong KM, Wistuba II, Biesterveld E, Ahmadian M, et al.  Abnormalities of fragile histidine trial genomic and complementary DNAs in cervical cancer: association with human papillomavirus subtype. J Nat Cancer Inst. 1998;90:433–439
  42. Mao L. Tumor suppressor genes: does FHIT fit?. J Nat Cancer Inst. 1998;90:412–414

PII: S1368-8375(02)00068-4

doi: 10.1016/S1368-8375(02)00068-4

Oral Oncology
Volume 38, Issue 8 , Pages 763-771 , December 2002